Jenkins Matthew P, Hill Anthony, Forte Antonietta F, Welch Verna L, True Jane M, Jones Charles H
Pfizer, New York, NY 10018, USA.
iScience. 2025 Aug 16;28(9):113385. doi: 10.1016/j.isci.2025.113385. eCollection 2025 Sep 19.
The adult vaccine market is undergoing rapid transformation, driven by an aging population and advancements in vaccine technology post-COVID. Research conducted in June 2022 highlights divergent stakeholder perspectives; policy makers and purchasers underestimate emerging challenges, while immunizers and consumers express concern about the increasingly complex vaccine landscape. Findings from over 750 participants reveal the need for strategic efforts to manage the integration of new vaccines and streamline communication among stakeholders. The study emphasizes improving data interoperability and adapting infrastructure, particularly through retail pharmacies, to meet rising demand. Collaborative efforts are critical to addressing bottlenecks and stakeholder overwhelm, ensuring a resilient vaccination ecosystem. This research provides actionable insights for navigating the evolving market and fostering success in a challenging era.
受人口老龄化和新冠疫情后疫苗技术进步的推动,成人疫苗市场正在经历快速转型。2022年6月进行的研究突出了利益相关者的不同观点;政策制定者和采购者低估了新出现的挑战,而免疫接种人员和消费者则对日益复杂的疫苗格局表示担忧。来自750多名参与者的调查结果显示,需要做出战略努力来管理新疫苗的整合,并简化利益相关者之间的沟通。该研究强调要改善数据互操作性并调整基础设施,特别是通过零售药店来满足不断增长的需求。合作努力对于解决瓶颈问题和避免利益相关者不堪重负至关重要,以确保建立一个有韧性的疫苗接种生态系统。这项研究为应对不断变化的市场和在充满挑战的时代取得成功提供了可操作的见解。